1. Home
  2. CLRB
  3. CLRB News

Latest Cellectar Biosciences Inc. (CLRB) News on November 17, 2024

Cellectar Biosciences and NorthStar Medical Radioisotopes Announce Partnership for Supply of Actinium-225
CLRB

GlobeNewswire

3 days ago

Cellectar Biosciences and NorthStar Medical Radioisotopes Announce Partnership for Supply of Actinium-225

Cellectar Biosciences and SpectronRx Partner to Manufacture Novel Phospholipid Radioconjugate for the Treatment of Cancer
CLRB

GlobeNewswire

5 days ago

Cellectar Biosciences and SpectronRx Partner to Manufacture Novel Phospholipid Radioconjugate for the Treatment of Cancer

Cellectar Biosciences to Report Third Quarter Financial Results and Host a Conference Call on Monday, November 18, 2024
CLRB

GlobeNewswire

6 days ago

Cellectar Biosciences to Report Third Quarter Financial Results and Host a Conference Call on Monday, November 18, 2024

Cellectar Selected to Present New Data from Phase 2 CLOVER-WaM Study in Oral Session at ASH 2024
CLRB

GlobeNewswire

11 days ago

Cellectar Selected to Present New Data from Phase 2 CLOVER-WaM Study in Oral Session at ASH 2024

Cellectar Biosciences Announces Compliance Regarding Filing of Form 10-Q
CLRB

GlobeNewswire

16 days ago

Cellectar Biosciences Announces Compliance Regarding Filing of Form 10-Q

Cellectar Biosciences to Present at IWWM Featuring Iopofosine I 131
CLRB

Zacks

3 months ago

Cellectar Biosciences to Present at IWWM Featuring Iopofosine I 131

Iopofosine I 131 Featured in Two Separate Presentations at 12th International Workshop on Waldenstrom’s Macroglobulinemia
CLRB

GlobeNewswire

3 months ago

Iopofosine I 131 Featured in Two Separate Presentations at 12th International Workshop on Waldenstrom’s Macroglobulinemia

Cellectar to Restate Previously Issued Financial Statements – Company Announces Receipt of Expected Delinquency Notification Letter from Nasdaq
CLRB

GlobeNewswire

3 months ago

Cellectar to Restate Previously Issued Financial Statements – Company Announces Receipt of Expected Delinquency Notification Letter from Nasdaq

Cellectar Biosciences Reports Financial Results for Q2 2024 and Provides a Corporate Update
CLRB

GlobeNewswire

3 months ago

Cellectar Biosciences Reports Financial Results for Q2 2024 and Provides a Corporate Update

UPDATE -- Cellectar Biosciences to Announce Second Quarter Financial Results and Host a Conference Call on Tuesday, August 13, 2024
CLRB

GlobeNewswire

3 months ago

UPDATE -- Cellectar Biosciences to Announce Second Quarter Financial Results and Host a Conference Call on Tuesday, August 13, 2024

Cellectar Biosciences to Announce First Quarter Financial Results and Host a Conference Call on Tuesday, August 13, 2024
CLRB

GlobeNewswire

3 months ago

Cellectar Biosciences to Announce First Quarter Financial Results and Host a Conference Call on Tuesday, August 13, 2024

CLRB

MT Newswires

4 months ago

Cellectar Shares Fall as Updated Data For Investigational Radiotherapy Shows Drop in Major Response Rate

CLRB

MT Newswires

4 months ago

Top Premarket Decliners

Cellectar Biosciences’ Iopofosine I 131 Exceeds Primary Endpoint in Waldenstrom’s Macroglobulinemia Pivotal Study with 78% of Major Response Patients Remaining Progression Free at 18 Months
CLRB

GlobeNewswire

4 months ago

Cellectar Biosciences’ Iopofosine I 131 Exceeds Primary Endpoint in Waldenstrom’s Macroglobulinemia Pivotal Study with 78% of Major Response Patients Remaining Progression Free at 18 Months

Cellectar Biosciences Announces Exercise of Tranche B Warrants and Purchase of New Warrants for Approximately $19.4 million with the Potential to Raise Up to an Additional $73.3 Million
CLRB

GlobeNewswire

4 months ago

Cellectar Biosciences Announces Exercise of Tranche B Warrants and Purchase of New Warrants for Approximately $19.4 million with the Potential to Raise Up to an Additional $73.3 Million

Cellectar Biosciences to Host Key Opinion Leader Event to Review the Full Results from Its CLOVER WaM Pivotal Trial and Waldenstrom’s Macroglobulinemia Market Landscape
CLRB

GlobeNewswire

5 months ago

Cellectar Biosciences to Host Key Opinion Leader Event to Review the Full Results from Its CLOVER WaM Pivotal Trial and Waldenstrom’s Macroglobulinemia Market Landscape

A Data-Driven Analysis of Netflix's Streaming Dominance and Future Outlook
CLRB

GuruFocus.com

5 months ago

A Data-Driven Analysis of Netflix's Streaming Dominance and Future Outlook

CLRB

Energy Global

5 months ago

ANDRITZ to equip new Silvan hydropower plant in Türkiye

Supreme Court Justice Alito talks polarization, his wife talks revenge in secret recordings
CLRB

USA TODAY

5 months ago

Supreme Court Justice Alito talks polarization, his wife talks revenge in secret recordings

Indra Energy Drives Sustainability Focus through the Penguins Pledge with the Pittsburgh Penguins
CLRB

Business Wire

5 months ago

Indra Energy Drives Sustainability Focus through the Penguins Pledge with the Pittsburgh Penguins

Pacer ETFs Rings in its 9th Anniversary as Firm nears $50 Billion in Assets Under Management
CLRB

Business Wire

5 months ago

Pacer ETFs Rings in its 9th Anniversary as Firm nears $50 Billion in Assets Under Management

SEALSQ to Launch Two New Quantum Resistant Chips
CLRB

GlobeNewswire

5 months ago

SEALSQ to Launch Two New Quantum Resistant Chips

Shrinking Fed rate cut expectations to keep US Treasury yields elevated: Reuters poll
CLRB

Reuters

5 months ago

Shrinking Fed rate cut expectations to keep US Treasury yields elevated: Reuters poll

Global Upstream Bioprocessing Market Analysis Report 2024-2030: A $59.24 Billion Market by 2030, Registering a CAGR of 14.3% from 2024 to 2030
CLRB

GlobeNewswire

5 months ago

Global Upstream Bioprocessing Market Analysis Report 2024-2030: A $59.24 Billion Market by 2030, Registering a CAGR of 14.3% from 2024 to 2030

Cellectar Biosciences and City of Hope Cancer Center Enter Collaboration to Evaluate Iopofosine I 131 in Mycosis Fungoides
CLRB

GlobeNewswire

6 months ago

Cellectar Biosciences and City of Hope Cancer Center Enter Collaboration to Evaluate Iopofosine I 131 in Mycosis Fungoides

Is Cellectar Biosciences (NASDAQ:CLRB) In A Good Position To Deliver On Growth Plans?
CLRB

Simply Wall St.

6 months ago

Is Cellectar Biosciences (NASDAQ:CLRB) In A Good Position To Deliver On Growth Plans?

CLRB

Thomson Reuters StreetEvents

6 months ago

Q1 2024 Cellectar Biosciences Inc Earnings Call

CLRB

GuruFocus.com

6 months ago

Cellectar Biosciences Inc (CLRB) Q1 2024 Earnings Call Transcript Highlights: Strategic ...

Cellectar Biosciences Reports Financial Results for Q1 2024 and Provides a Corporate Update
CLRB

GlobeNewswire

6 months ago

Cellectar Biosciences Reports Financial Results for Q1 2024 and Provides a Corporate Update

Cellectar Biosciences to Present at the Guggenheim Healthcare Talks Radiopharmaceuticals Day
CLRB

GlobeNewswire

6 months ago

Cellectar Biosciences to Present at the Guggenheim Healthcare Talks Radiopharmaceuticals Day

Cellectar Biosciences to Announce First Quarter Financial Results and Host a Conference Call on Tuesday, May 14, 2024
CLRB

GlobeNewswire

6 months ago

Cellectar Biosciences to Announce First Quarter Financial Results and Host a Conference Call on Tuesday, May 14, 2024

Cellectar Biosciences, Inc. (NASDAQ:CLRB): When Will It Breakeven?
CLRB

Simply Wall St.

8 months ago

Cellectar Biosciences, Inc. (NASDAQ:CLRB): When Will It Breakeven?

Cellectar Biosciences, Inc. (NASDAQ:CLRB) Q4 2023 Earnings Call Transcript
CLRB

Insider Monkey

8 months ago

Cellectar Biosciences, Inc. (NASDAQ:CLRB) Q4 2023 Earnings Call Transcript

CLRB

Thomson Reuters StreetEvents

8 months ago

Q4 2023 Cellectar Biosciences Inc Earnings Call

Cellectar Biosciences Reports Financial Results for Year Ended 2023 and Provides a Corporate Update
CLRB

GlobeNewswire

8 months ago

Cellectar Biosciences Reports Financial Results for Year Ended 2023 and Provides a Corporate Update

Cellectar Biosciences to Announce 2023 Year End Earnings Results and Host a Conference Call on Wednesday, March 27, 2024
CLRB

GlobeNewswire

8 months ago

Cellectar Biosciences to Announce 2023 Year End Earnings Results and Host a Conference Call on Wednesday, March 27, 2024

Cellectar Biosciences to Present at the 36th Annual Roth Conference
CLRB

GlobeNewswire

8 months ago

Cellectar Biosciences to Present at the 36th Annual Roth Conference

Cellectar Biosciences Reports High Rate of Complete Remission in Investigator Initiated Phase I Study of Iopofosine in Combination with External Beam Radiotherapy in Recurrent Head and Neck Cancer
CLRB

GlobeNewswire

8 months ago

Cellectar Biosciences Reports High Rate of Complete Remission in Investigator Initiated Phase I Study of Iopofosine in Combination with External Beam Radiotherapy in Recurrent Head and Neck Cancer

Cellectar Biosciences to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
CLRB

GlobeNewswire

9 months ago

Cellectar Biosciences to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Cellectar Biosciences Announces Enrollment of the First Patient in Pediatric High-Grade Gliomas Phase 1b Clinical Study
CLRB

GlobeNewswire

10 months ago

Cellectar Biosciences Announces Enrollment of the First Patient in Pediatric High-Grade Gliomas Phase 1b Clinical Study

CLRB

Associated Press Finance

10 months ago

Chemung Financial: Q4 Earnings Snapshot

Chemung Financial Corp (CHMG) Announces Annual and Q4 Earnings: A Mixed Financial Performance ...
CLRB

GuruFocus.com

10 months ago

Chemung Financial Corp (CHMG) Announces Annual and Q4 Earnings: A Mixed Financial Performance ...

ESGEN Acquisition Corp. Announces Updated Transaction Terms for its Pending Business Combination with Sunergy Renewables
CLRB

GlobeNewswire

10 months ago

ESGEN Acquisition Corp. Announces Updated Transaction Terms for its Pending Business Combination with Sunergy Renewables

Cellectar Biosciences Announces Tranche A Warrants Fully Exercised, Providing Proceeds of $44.1 Million
CLRB

GlobeNewswire

10 months ago

Cellectar Biosciences Announces Tranche A Warrants Fully Exercised, Providing Proceeds of $44.1 Million

Bakkt Crypto Capabilities Activated Across Multiple International Regions
CLRB

Business Wire

10 months ago

Bakkt Crypto Capabilities Activated Across Multiple International Regions

Cellectar Biosciences Reports Complete Central Nervous System (CNS) Clearance in Relapsed/Refractory Waldenstrom’s Macroglobulinemia Patient
CLRB

GlobeNewswire

10 months ago

Cellectar Biosciences Reports Complete Central Nervous System (CNS) Clearance in Relapsed/Refractory Waldenstrom’s Macroglobulinemia Patient

Why Calavo Growers Stock Dropped Today
CLRB

Motley Fool

10 months ago

Why Calavo Growers Stock Dropped Today

Wrap Technologies, Inc. Appoints Scot Cohen as Chief Executive Officer
CLRB

GlobeNewswire

10 months ago

Wrap Technologies, Inc. Appoints Scot Cohen as Chief Executive Officer

Cellectar Biosciences Broadens Pipeline with Targeted Alpha Therapy (TAT) for Solid Tumors and Releases Promising Preclinical Data
CLRB

GlobeNewswire

10 months ago

Cellectar Biosciences Broadens Pipeline with Targeted Alpha Therapy (TAT) for Solid Tumors and Releases Promising Preclinical Data

Cellectar Biosciences to Host Conference Call with Texas Oncology Hematologist M. Yair Levy, M.D. on January 19, 2024 to Discuss Iopofosine I 131 Pivotal Topline Results
CLRB

GlobeNewswire

10 months ago

Cellectar Biosciences to Host Conference Call with Texas Oncology Hematologist M. Yair Levy, M.D. on January 19, 2024 to Discuss Iopofosine I 131 Pivotal Topline Results

Cellectar Biosciences Partners with MiBA, a Data Subsidiary of American Oncology Network, to Advance the Treatment of Waldenstrom's Macroglobulinemia in the Community Setting
CLRB

GlobeNewswire

10 months ago

Cellectar Biosciences Partners with MiBA, a Data Subsidiary of American Oncology Network, to Advance the Treatment of Waldenstrom's Macroglobulinemia in the Community Setting

CLRB

Reuters

10 months ago

Cellectar's blood cancer therapy succeeds in trial

Cellectar Biosciences Announces Positive Topline Data Achieving Primary Endpoint in Pivotal Clinical Study of Iopofosine I 131 in Waldenstrom’s Macroglobulinemia
CLRB

GlobeNewswire

10 months ago

Cellectar Biosciences Announces Positive Topline Data Achieving Primary Endpoint in Pivotal Clinical Study of Iopofosine I 131 in Waldenstrom’s Macroglobulinemia

Billionaire Louis Bacon’s 15 Long-Term Stock Picks
CLRB

Insider Monkey

10 months ago

Billionaire Louis Bacon’s 15 Long-Term Stock Picks

Emeren Group Purchases an 86 MWp Solar Portfolio in Spain
CLRB

PR Newswire

a year ago

Emeren Group Purchases an 86 MWp Solar Portfolio in Spain

Pathfinder Bancorp, Inc. Declares Dividend
CLRB

GlobeNewswire

a year ago

Pathfinder Bancorp, Inc. Declares Dividend

Five Point Holdings, LLC Announces Early Participation Deadline Results for the Previously Announced Exchange Offer and Consent Solicitation
CLRB

Business Wire

a year ago

Five Point Holdings, LLC Announces Early Participation Deadline Results for the Previously Announced Exchange Offer and Consent Solicitation

Tayon Named Chief Product Officer at American Outdoor Brands
CLRB

PR Newswire

a year ago

Tayon Named Chief Product Officer at American Outdoor Brands

Bicycle Therapeutics Provides Data Updates for Three Clinical Programs and Strategy Overview at First R&D Day
CLRB

Business Wire

a year ago

Bicycle Therapeutics Provides Data Updates for Three Clinical Programs and Strategy Overview at First R&D Day

CLRB

Zacks Small Cap Research

a year ago

MSCLF: AAK1 Disclosed as Drug Target for DMD Program…

12 Best Healthcare Stocks For the Long-Term
CLRB

Insider Monkey

a year ago

12 Best Healthcare Stocks For the Long-Term

Lexicon Enrolls First Patient in Phase 2b Progress Study of LX9211 in Diabetic Peripheral Neuropathic Pain (DPNP)
CLRB

GlobeNewswire

a year ago

Lexicon Enrolls First Patient in Phase 2b Progress Study of LX9211 in Diabetic Peripheral Neuropathic Pain (DPNP)

Cogent Biosciences Announces Poster Presentations at Upcoming San Antonio Breast Cancer Symposium
CLRB

GlobeNewswire

a year ago

Cogent Biosciences Announces Poster Presentations at Upcoming San Antonio Breast Cancer Symposium

12 Best Recycling Stocks To Buy Now
CLRB

Insider Monkey

a year ago

12 Best Recycling Stocks To Buy Now

3 Medical Services Stocks to Buy as Industry Trends Improve
CLRB

Zacks

a year ago

3 Medical Services Stocks to Buy as Industry Trends Improve

Platinum Group Metals Ltd. Reports 2023 Annual Results
CLRB

Newsfile

a year ago

Platinum Group Metals Ltd. Reports 2023 Annual Results

Destra Multi Alternative Fund Announces the Approval of an Amended and Restated Declaration of Trust
CLRB

Business Wire

a year ago

Destra Multi Alternative Fund Announces the Approval of an Amended and Restated Declaration of Trust

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q3 2023 Earnings Call Transcript
CLRB

Insider Monkey

a year ago

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q3 2023 Earnings Call Transcript

J.W. Mays' (NASDAQ:MAYS) investors will be pleased with their favorable 90% return over the last three years
CLRB

Simply Wall St.

a year ago

J.W. Mays' (NASDAQ:MAYS) investors will be pleased with their favorable 90% return over the last three years

Acumen Pharmaceuticals Secures $50.0 Million Credit Facility with K2 HealthVentures
CLRB

GlobeNewswire

a year ago

Acumen Pharmaceuticals Secures $50.0 Million Credit Facility with K2 HealthVentures

Dividend Investors: Don't Be Too Quick To Buy BGSF, Inc. (NYSE:BGSF) For Its Upcoming Dividend
CLRB

Simply Wall St.

a year ago

Dividend Investors: Don't Be Too Quick To Buy BGSF, Inc. (NYSE:BGSF) For Its Upcoming Dividend

Fossil Group, Inc. (NASDAQ:FOSL) Q3 2023 Earnings Call Transcript
CLRB

Insider Monkey

a year ago

Fossil Group, Inc. (NASDAQ:FOSL) Q3 2023 Earnings Call Transcript

12 Best Day Trading Stocks To Buy
CLRB

Insider Monkey

a year ago

12 Best Day Trading Stocks To Buy

PEDEVCO Announces Q3 2023 Financial Results and Operations Update
CLRB

ACCESSWIRE

a year ago

PEDEVCO Announces Q3 2023 Financial Results and Operations Update

BeautyHealth to Report Third Quarter 2023 Financial Results on November 13, 2023
CLRB

Business Wire

a year ago

BeautyHealth to Report Third Quarter 2023 Financial Results on November 13, 2023

Share on Social Networks: